Projects
MIME supports clinical research across all medical specialties and themes, which are underpinned by deep expertise across a range of disciplines, including:
Our outputs include medical devices, diagnostic devices, imaging technologies, therapeutics drug delivery systems, regenerative medicine and stem cell technologies such as bioreactors and drug screening, digital health technologies, surgical robotics, and clinical tools.
Flagship projects

MIME has generously supported cardiovascular engineering research at Monash University over a number of years through seed grants and top-up grants (among others) for our team at the CREATElab. Some of these funds have been directly used to support early research that produced pilot data for our recently successful Artificial Heart Frontiers Program (AHFP) which received a $50M grant from the Medical Research Future Fund (MRFF). The AHFP focuses on three core devices to treat patients with heart failure, with one of those devices started at Monash University through funding from MIME. The AHFP, and myself personally, sincerely thank MIME for their support over many years which has led to substantially larger initiatives and, hopefully, translation into better patient outcomes in the near future."
ASSOCIATE PROFESSOR SHAUN GREGORY
About the Total Artificial Heart
The Total Artificial Heart will be a game-changer for the treatment of heart failure in Australia. It is expected to reduce the numbers of deaths by heart failure while improving longevity and quality of life. Unlike previous devices, it promises to be durable for more than 10 years, is small enough to implant in a child, and powerful enough for an adult. It will allow patients to maintain an active lifestyle and improve their quality of life.
The program is also expected to drive significant benefits to the Australian economy through savings to the healthcare system, job creation and labour force benefits and additional revenue. Since 2015 MIME has provided the project co-leads a total of $970,000 funding for research and commercialisation support.